New Report Bio-Implants Market Forecasts up to 2017 By MarketsandMarkets
Linkedin

New Report Bio-Implants Market Forecasts up to 2017 By MarketsandMarkets

Amsterdam : Netherlands | Sep 17, 2012 at 5:43 AM PDT
Source: PRWeb
XX XX
Views: Pending
 

September 17, 2012

The “Bio-Implants Market (Cardiovascular, Orthopaedics, Neurostimulation, Xenografts, Allografts and Others) Competitive Analysis and Global Forecast to 2017” published by MarketsandMarkets (http://www.marketsandmarkets.com), analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse 83 tables spread through 195 pages and in-depth TOC on “Bio-Implants Market (Cardiovascular, Orthopaedics, Neurostimulation, Xenografts, Allografts and Others) Competitive Analysis and Global Forecast to 2017”.
http://www.marketsandmarkets.com/Market-Reports/bio-implants-market-728.html
Early buyers will receive 10% customization on reports.

This report studies the global bio-implants market with forecast from 2012 to 2017.

Bio-implants are defined as bioengineered products, employed in tissues or in human living cells with the assistance of active agents or synthetic constructs used to reproduce certain physiological functions or to treat the cause of the disease. The bio-implants market has brought about a paradigm shift in the medical device industry with more demand for biological implants in cardiology, vascular therapy, orthopaedics, trauma, spine, dental, and wound care divisions. Certain bioactive implants such as drug eluting stents, hormonal implants, and implantable drug pumps also form part of this market.

The global bio-implants market was valued at $94.1 billion in the year 2012; North America was the largest market, followed by Europe, and Asia. The U.S. market is expected to face a slump in the coming years due to austerity measures taken by the Federal Government and rise in taxation caused due to the economic crisis of 2008. Uncertainty also prevails in the European region with the Euro crisis; hence, growth is expected to be minimal in this region for the next five years. Asia, however, will showcase higher growth mainly due to large investments from foreign firms and government funding.

The major players in bio-implants market are Stryker Corporation (U.S.), Synthes (U.S.), Boston Scientific Corporation (U.S.), Biomet, Inc. (U.S.), Smith and Nephew (U.K.), Medtronic (U.S.), St. Jude Medical, Inc. (U.S.), and Tornier N.V. (The Netherlands).

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales (at) marketsandmarkets (dot) com
MarketsandMarkets Blog
http://twitter.com/marketsmarkets

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebbio-implants/market/prweb9909228.htm

 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.